Recursion Pharmaceuticals (RXRX) Capital Expenditures Growth (5y) (2025 - 2026)

Recursion Pharmaceuticals (RXRX) Capital Expenditures Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	69,146.49 Bn	69,146.20 Bn	-
2	Nanobiotix	1,942.19 Bn	1,942.13 Bn	-
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-
4	BeOne Medicines	475.42 Bn	470.63 Bn	1.35 Bn
5	Vertex Pharmaceuticals	123.32 Bn	116.08 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.80 Bn	61.04 Bn	3.31 Bn
7	Belite Bio	63.28 Bn	63.28 Bn	-
8	Argenx Se	56.67 Bn	51.48 Bn	1.41 Bn
9	Revolution Medicines	38.15 Bn	38.15 Bn	-
10	Recursion Pharmaceuticals	1.65 Bn	986.15 Mn	-6.02 Mn

Download Data